Pharmerica (PMC) Reports In-Line Q2 EPS

Pharmerica (NYSE: PMC) reported Q2 EPS of $0.47, in-line with the analyst estimate of $0.47. Revenue for the quarter came in at $519.6 million versus the consensus estimate of $508.31 million.Pharmerica reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Pharmerica (PMC) click here.

You May Also Be Interested In

• What Delta’s report tells investors in American and United
• Benchmark Reiterates Buy Rating on Penske Automotive Group (PAG)
• Piper Sandler on FirstSun Capital Bancorp (FSUN): 'We expect shares to underperform on Friday'